John Woodland Postdoctoral Medicinal Chemist Drug Discovery Youtube Scientific background. 2021–2022: junior research fellow in chemical biology. from 2021 to 2022 i was appointed as a junior research fellow at the holistic drug discovery and development (h3d) centre and in the department of chemistry at the university of cape town (uct) under the mentorship of professor kelly chibale. 2021. plasmodium kinase inhibitors as potential multistage active antimalarials. john g. woodland and kelly chibale, chapter 12 in 2021 medicinal chemistry reviews (volume 56), american chemical society (medicinal chemistry division), 2021. issn 2575 9175.
Dr John Woodland Drug Discovery And Development Centre H3d This is a continuation of my previous role at the h3d centre: (1) contributing to chemical biology and medicinal chemistry aspects of drug discovery projects and supervising postgraduate students, and (2) assisting in capacity building initiatives to train mentor scientists and. Dr john woodland. john supports the work at the h3d centre by contributing to chemical biology and medicinal chemistry aspects of malaria drug discovery projects, supervising postgraduate students in professor kelly chiable’s academic research group, and supporting h3d’s capacity building initiatives. after obtaining his phd in chemistry. John woodland, a postdoctoral medicinal chemist at the university of cape town in south africa, works in the only integrated drug discovery platform in all of africa.his research, which focuses on designing and synthesising potential drug leads for infectious diseases like malaria, has come to a standstill. John woodland and kelly chibale retrace the tumultuous history of quinine from a medicine — used as a tool for colonialism — to a puzzling chemical target, a fluorescence standard and a key.
Comments are closed.